Portland health startup MedRhythms grows pipeline with new clinical trial, scientific board

MedRhythms Inc., a Portland health technology startup, is beginning a new clinical trial of the company’s digital therapeutic device for walking impairments related to Parkinson’s disease.

The multisite study will be conducted through a collaboration with Boston University and a leading hospital, and will evaluate the efficacy of the device when used at home, according to a news release.

MedRhythms, launched in 2016, is developing systems with clinical-grade sensors, music and artificial intelligence to measure and improve walking for people with neurological injuries or diseases. Read more

Related Posts

UNE receives $10.8 million to establish new Center for Cell Signaling Research

The University of New England has received a five-year, $10.8 million award from the National Institutes of Health to support an...

18 January 2024

Jackson Lab opens $4.5M on-site child care center in Bar Harbor

Anewly constructed child care center on the Jackson Laboratory’s Bar Harbor campus is seen as an important draw for employees that also...

17 January 2024

From med tech to skin care: Top Gun names 41 startups to 2024 lineup

Out of 57 companies that applied to Maine’s 2024 Top Gun business accelerator program, 41 have been accepted and will receive help...

16 January 2024